Skip to main content

Accuray Incorporated (ARAY)

NASDAQ: ARAY · IEX Real-Time Price · USD
5.12
-0.17 (-3.21%)
At close: Nov 26, 2021 1:00 PM
5.27
0.15 (2.93%)
After-hours:Nov 26, 2021 3:47 PM EST
Market Cap465.51M
Revenue (ttm)418.40M
Net Income (ttm)-7.74M
Shares Out90.92M
EPS (ttm)-0.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,802,092
Open5.71
Previous Close5.29
Day's Range4.93 - 5.18
52-Week Range3.46 - 6.02
Beta1.87
AnalystsStrong Buy
Price Target8.50 (+66.0%)
Earnings DateNov 3, 2021

About ARAY

Accuray Incorporated develops, manufactures, and sells radiotherapy systems for alternative cancer treatments in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact Sy...

IndustryHealth Care Equipment & Supplies
IPO DateFeb 8, 2007
CEOJoshua Levine
Employees995
Stock ExchangeNASDAQ
Ticker SymbolARAY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Accuray stock is "Strong Buy." The 12-month stock price forecast is 8.50, which is an increase of 66.02% from the latest price.

Price Target
$8.50
(66.02% upside)
Analyst Consensus: Strong Buy

News

After Golden Cross, Accuray (ARAY)'s Technical Outlook is Bright

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

2 days ago - Zacks Investment Research

Earnings Estimates Rising for Accuray (ARAY): Will It Gain?

Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

1 week ago - Zacks Investment Research

Here's What Could Help Accuray (ARAY) Maintain Its Recent Price Strength

If you are looking for stocks that are well positioned to maintain their recent uptrend, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Str...

1 week ago - Zacks Investment Research

Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively T...

SUNNYVALE, Calif., Nov. 10, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that more than two decades of globally-driven clinical data support the use of the company's CyberKni...

2 weeks ago - PRNewsWire

Accuray To Participate at Stifel 2021 Virtual Healthcare Conference

SUNNYVALE, Calif., Nov. 9, 2021 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced its participation in Stifel's 2021 Virtual Healthcare Conference.

2 weeks ago - PRNewsWire

3 Penny Stocks To Add to Your Watchlist This Month November

Are these penny stocks on your watchlist? The post 3 Penny Stocks To Add to Your Watchlist This Month November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:FAMINXTP
3 weeks ago - PennyStocks

Accuray (ARAY) Q1 Earnings Beat Estimates, Margins Down

Accuray (ARAY) registers growth in both Service and Product revenues during fiscal Q1.

3 weeks ago - Zacks Investment Research

Accuray Reports Fiscal 2022 First Quarter Financial Results

SUNNYVALE, Calif., Nov. 3, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2022 ended September 30, 2021.

3 weeks ago - PRNewsWire

Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer P...

SUNNYVALE, Calif., Oct. 25, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology  found early-stage breast cancer patients could exper...

1 month ago - PRNewsWire

Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range b...

SUNNYVALE, Calif., Oct. 21, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), today announced preliminary financial results for the first quarter of fiscal 2022 ended September 30, 2021.

1 month ago - PRNewsWire

Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021

SUNNYVALE, Calif., Oct. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is showcasing its new VOLO™ Ultra for the Radixact ® System, at ASTRO 2021.

1 month ago - PRNewsWire

Accuray to Report First Quarter Fiscal 2022 Financial Results on November 3, 2021

SUNNYVALE, Calif., Oct. 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2022, ended September 30, 2021, after the market c...

1 month ago - PRNewsWire

Accuray (ARAY), C-RAD Ink Deal to Enhance Breast Cancer Treatment

Accuray's (ARAY) latest agreement is likely to improve breast cancer treatment.

1 month ago - Zacks Investment Research

Accuray to Host ASTRO Analyst & Investor Meeting on October 25, 2021

SUNNYVALE, Calif., Oct. 12, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host an Analyst & Investor Meeting on Monday, October 25, 2021, in conjunction ...

1 month ago - PRNewsWire

Accuray's (ARAY) Radiotherapy Technologies Adopted by Unicancer

Accuray's (ARAY) proprietary radiotherapy technologies get selected by Unicancer, which is the largest network of comprehensive cancer centers in Europe.

1 month ago - Zacks Investment Research

C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities

UPPSALA, Sweden, and SUNNYVALE, Calif., Oct. 4, 2021 /PRNewswire/ -- C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to...

1 month ago - PRNewsWire

French Hospital Network Unicancer Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT...

SUNNYVALE, Calif., Sept. 29, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Unicancer has selected three Radixact ®  Systems with the ClearRT ™ helical fan-beam kVCT imagi...

1 month ago - PRNewsWire

Nagoya City University Hospital is First in Japan to Treat Cancer Patients Using the Accuray Radixact® System with Cl...

SUNNYVALE, Calif., Sept. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Nagoya City University Hospital in Aichi has treated the first cancer patient in Japan usin...

2 months ago - PRNewsWire

Accuray's (ARAY) CyberKnife Favored For Prostate Cancer Treatment

Per the PACE trial data, patients treated with Accuray's (ARAY) CyberKnife SBRT are likely to experience lesser bladder-related side effects unlike conventional linear accelerator.

2 months ago - Zacks Investment Research

Accuray CyberKnife® Robotic Radiotherapy Platform is Superior to Conventional Linear Accelerators in Reducing Inciden...

SUNNYVALE, Calif., Sept. 14, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from the PACE – Prostate Advances in Comparative Evidence – trial indicate the company's C...

2 months ago - PRNewsWire

Why Is Accuray (ARAY) Down 3.4% Since Last Earnings Report?

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

Mika Nishimura Joins Accuray Board of Directors

SUNNYVALE, Calif., Aug. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Mika Nishimura to the company's Board of Directors, effective as of August 17, 2021.

3 months ago - PRNewsWire

Accuray (ARAY) Posts In-Line Q4 Earnings, Beats on Revenues

Accuray (ARAY) registers growth in Service and Product revenues during fiscal Q4.

3 months ago - Zacks Investment Research

Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates

Accuray (ARAY) delivered earnings and revenue surprises of 0.00% and 9.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Accuray Reports Fourth Quarter and Fiscal 2021 Financial Results

SUNNYVALE, Calif., Aug. 11, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2021.

3 months ago - PRNewsWire